Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Juvenile Polyposis Syndrome is a rare, inherited disorder characterized by the development of multiple polyps (non-cancerous growths) in the gastrointestinal tract, especially in the large intestine (colon).
read more about juvenile polyposis syndrome ...The cause is a mutation in genes like BMPR1A or SMAD4, which are tumor suppressor genes that normally help regulate cell growth in the gut lining. The failure of these genes predisposes the person to developing numerous benign polyps, typically before the age of 20. These polyps contain specific cellular characteristics (juvenile histology) and carry a high risk of developing into colon cancer later in life. The continuous formation of polyps is the defining feature, often requiring careful endoscopic surveillance to mitigate the lifetime cancer risk.
Symptoms include gastrointestinal bleeding, which is often found microscopically in the stool or can cause severe, chronic anemia (low red blood cell count). The polyps, particularly if large, can lead to intestinal obstruction or intussusception (telescoping of the bowel), causing acute abdominal pain.
Patients may also experience chronic diarrhea, or a severe condition called protein-losing enteropathy (protein loss in the gut), which leads to generalized body swelling. Any bleeding requires immediate investigation, as it signals potential malignant change or internal trauma.
Juvenile Polyposis Syndrome does not directly impact vision. However, the associated chronic bleeding from the polyps often leads to severe anemia (low red blood cell count). Severe systemic anemia can cause temporary visual symptoms like blurred vision, fatigue, and paleness of the conjunctiva.
Diagnosis relies on performing an endoscopy or colonoscopy to visualize and count the polyps. Genetic testing is often used to confirm the mutation in the SMAD4 gene, which is associated with a specific, higher risk of cancer and other systemic issues.
Necessary screening involves frequent, regular colonoscopies to remove polyps before they become cancerous. Treatment may involve surgery to remove a large section of the colon (colectomy) if the polyps are too numerous or if cancer develops.
The polyps themselves are benign, but they have a high potential to become cancerous over time.
No, Juvenile Polyposis Syndrome is a rare genetic disorder.
Yes, the SMAD4 gene mutation is also linked to vascular and skin abnormalities.
If your child has rectal bleeding or anemia, seek a genetic consultation. JPS requires frequent endoscopic surveillance to remove polyps before they transform. If the SMAD4 gene is involved, your doctor must also screen for "Hereditary Hemorrhagic Telangiectasia" (HHT).
National Cancer Institute. Juvenile Polyposis Syndrome (cancer.gov). 2024.
Cleveland Clinic. Juvenile Polyposis (clevelandclinic.org). 2024.
NORD. Juvenile Polyposis Syndrome (rarediseases.org). 2024.
StatPearls. Juvenile Polyposis Syndrome (ncbi.nlm.nih.gov). 2024.